Sphera Funds Management’s Immune Design Corp. IMDZ Stock Holding History

Sphera Funds Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-103,000	Closed	-$567K	–	137
2016 Q4	$567K	Sell	103,000 -100,000	-49%	-$706K	0.14%	90
2016 Q3	$1.54M	Buy	203,000 +50,000	+33%	+$366K	0.25%	83
2016 Q2	$1.25M	Hold	153,000	–	–	0.32%	72
2016 Q1	$1.99M	Hold	153,000	–	–	0.43%	51
2015 Q4	$3.07M	Sell	153,000 -17,000	-10%	-$293K	0.45%	56
2015 Q3	$2.07M	Buy	170,000 +30,000	+21%	+$562K	0.26%	90
2015 Q2	$2.89M	Buy	140,000 +10,560	+8%	+$249K	0.28%	91
2015 Q1	$2.73M	Buy	+129,440	New	+$3.38M	0.28%	90

Other funds holding IMDZ

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Sphera Funds Management's IMDZ Position: Q1 2017 in Review

Sphera Funds Management sold out of Immune Design Corp. (IMDZ) in Q1 2017, closing a stake of 103,000 shares — an estimated $567K sold.

Sphera Funds Management first reported a position in IMDZ in Q1 2015 and held it in 8 quarters. The position peaked at $3.07M in Q4 2015. 58 funds tracked by Wall St. Rank hold IMDZ as of Q1 2017.

Sphera Funds Management reported no remaining Immune Design Corp. position as of Q1 2017 after selling out during the quarter.
Sphera Funds Management sold 103,000 Immune Design Corp. shares in Q1 2017, an estimated $567K.
Sphera Funds Management first reported a position in Immune Design Corp. in Q1 2015 and held it in 8 quarters.
Sphera Funds Management's Immune Design Corp. position peaked at $3.07M in Q4 2015.
58 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2017.

Based on Sphera Funds Management's 13F filing for Q1 2017, filed 11 May 2017.